M

Memphasys
MEM

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
A$8.96M
EV
A$13.87M
Shares Outstanding
2.24B
Beta
0.15
Industry
Biotechnology

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E 2026E
-
P/Revenue 2026E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Memphasys Limited

gainify

M

Memphasys Limited

MEM

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company primarily develops Felix, a device separates sperm from raw seme...

Sector

Healthcare

Industry

Biotechnology

CEO

Ali, David

Employees

24

IPO Date

2007-05-11

Headquarters

34 Richmond Road, Level 1, Homebush, New South Wales, 2140, Australia

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.